Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

NOVATO, Calif., Oct. 28 /PRNewswire-FirstCall/ -- 

    Financial Highlights ($ in millions, except per share data)

    Item                   Q3 2009                Q3 2008 Comparison
    Total BioMarin
     Revenue               $80.8                  11% increase
    Total Net Product
     Revenue               $78.4                  16% increase
    Naglazyme Net
     Product Revenue       $42.1                  26% increase
    Aldurazyme BioMarin
     Net Product Revenue   $14.6                  $20.7 ($5.6 net inventory
                                                  transfer)
    Kuvan Net Product
     Revenue               $21.7                  57% increase
    GAAP Net Income        $6.6                   $0.8
    GAAP Net Income
     per share             $0.07 (basic),         $0.01 (basic and diluted)
                            $0.06 (diluted)
    Non-GAAP Net Income    $15.5                  $8.2
    Non-GAAP Net Income
     per share             $0.16 (basic),         $0.08 (basic and diluted)
                            $0.13 (diluted)

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced financial results for the third quarter ended September 30, 2009. GAAP net income was $6.6 million ($0.06 per diluted share) for the third quarter of 2009, compared to GAAP net income of $0.8 million ($0.01 per diluted share) for the third quarter of 2008. Non-GAAP net income was $15.5 million ($0.13 per diluted share) for the third quarter of 2009, compared to non-GAAP net income of $8.2 million ($0.08 per diluted share) for the third quarter of 2008. Non-GAAP net income excludes non-cash stock compensation expense, certain nonrecurring material items and the tax effect of the adjustments. The reconciliation of the non-GAAP measures to the estimated GAAP net income is detailed in the table provided at the end of
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  IsoRay, Inc. (AMEX: ISR ... entered into an exclusive international distribution agreement with IASIS ... in Greece . IsoRay is a ... medical radioisotope applications for brain cancer, lung cancer, head ... IASIS Medical is ideally suited to ...
(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...
(Date:5/21/2013)... May 21, 2013 BioElectronics Corp. (PINKSHEETS: ... electronic devices, announced that CEO, Andrew ... the FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation ... for over the counter sales. "It,s ... medical device classification schema," Whelan said.  "While the ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... DUBLIN, Jan. 11, 2011 Amarin Corporation plc (Nasdaq: ... a focus on cardiovascular disease, today announced that it has ... Shares ("ADSs") at a price to the public of $7.60 ... of the underwriters, over-allotment option, the company sold a total ...
... Newell Robinson, M.D., Chairman of the Department ... Director of Interventional Cardiovascular Procedures; Andrew Berke, M.D., ... at St. Francis Hospital, The Heart Center® are ... a device that may offer new hope for ...
Cached Medicine Technology:Amarin Announces Successful Completion of Offering of American Depositary Shares 2Amarin Announces Successful Completion of Offering of American Depositary Shares 3St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement 2
(Date:5/21/2013)... Parker Waichman LLP, a national law firm dedicated ... devices, is offering remarks on the closing argument of the ... E. Taylor v. Intuitive Surgical, 09-2-03136-5, Superior Court, State of ... Bloomberg report noted that the plaintiff’s attorney, after noting ... how it deployed its strategy to train doctors to use ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Parker Waichman ... rights of victims injured by defective medical devices, is ... & Joint Surgery on May 15, 2013. The study ... to identify complications that occur in patients with metal-on-metal ... failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve ...
(Date:5/21/2013)... 21 May 2013, Paris, France: One-year results from SOURCE ... valve implantation (TAVI) registries to-date reported today at ... practice, with high rates of device success for all ... SOURCE XT Post-Approval Study followed up 2688 consecutively enrolled ... Sapien XT heart valve at 93 centres in 17 ...
(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Wright Conserve hip replacement lawsuits in ... an Order in response to a request from Plaintiffs’ ... of the Defendant. The May 17th Order grants ... interviews may be conducted. (In re: Wright Medical Technology, ...
(Date:5/21/2013)... 2013 Global Proving Ground (GPG), a ... largest online retailer of health and fitness supplements, are ... show, Warrior Island. “We cast the show by ... Twitter, with our unique social networking platform,” states show’s ... fighters on an island in the Pacific Ocean, where ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3
... room in the intensive care unit previously ... may increase the odds of acquiring such ... illness and death in hospitals: methicillin-resistant Staphylococcus ... to background information in the article. Researchers ...
... latest to join the fight against HIV with their services ... have been recruited as part of an innovative program to ... government. This donation is expected to aid in the funding ... testing and encouraging safer sex. ,The British ...
... the HIV/AIDS prevalence rate in Kenya from 6.1% in 2005 ... Council of Kenya (NACC) released the latest data, according to ... % whereas in rural areas it is 4.6%.,A variety of ... pregnant HIV-positive mothers from passing the virus to their babies, ...
... oily fish during pregnancy may increase the risk of ... high mercury levels in oily fish like mackerel, salmon ... experts say that it is essential for everybody including ... ,According to the Food Standards Agency, pregnant ...
... different work places were at higher risk for breast cancer. ... on a farm have a risk of breast cancer that ... study also found out that women working in healthcare and ... cancer than the national average.,This study, conducted by researchers at ...
... a very different kind of war for Prem Khullar. Here ... bacteria, not civilian populations//. And the retired air force squadron ... years. ,What began in 1993 as a one-room ... (ABLE). Made possible through generous NRI funding and local land ...
Cached Medicine News:Health News:Transmission of Antibiotic-Resistant Bacteria Linked to Previous ICU Room Occupants 2Health News:Decrease in AIDS prevalence rate in Kenya 2Health News:Premature Delivery due to Oily fish 2
Open ring design for globe fixation during various ocular procedures. Blunt fixation points. Swivel handle provides increased flexibility. Manufactured in titanium....
Open ring design for globe fixation during various ocular procedures. Blunt fixation points. Swivel handle provides increased flexibility. Manufactured in titanium....
Open 14 mm fixation ring with teeth to prevent damage to conjuctiva. Gauge is marked every 10 degrees to determine the extent of the arc to be incised. Two broad marks align with steep axis....
Fixation ring with atraumatic teeth provides excellent stabilization and pressure on globe. Round knurled handle with dull finish....
Medicine Products: